Oil jumps on vaccine news, gold slides
Multiple States And FDA Warn Of "Careless" Rapid Antigen Testing In Asymptomatic COVID Cases
Pfizer, BioNTech Announce COVID-19 Vaccine is 90% Effective; Shares Pop in Pre-Market Trading
Novartis’ Ilaris fails in late-stage COVID-19 trial
Novavax, Australia Ink Deal For 40M Covid Vaccine Doses; Shares Rise
Hilton Surprises With Quarterly Profit As Demand Steps Up; Shares Gain
TFF Teams Up With Augmenta For Covid-19 Antibody Therapies; Shares Pop 7%
BDX Inks Deal With Dutch Gov. For 9M Covid-19 Antigen Tests
Humanigen Treats First Patient in Late-Stage COVID-19 Trial
All Eyes on Moderna's COVID-19 Vaccine Ahead of Data Readout
Impressive Turnaround Puts General Electric Stock on the Right Track, Says Analyst
Regeneron posts second look on Covid-19 antibody cocktail, boosting its case for EUA — but what about symptom alleviation?
United trials free COVID-19 testing on transatlantic routes
Eli Lilly Strikes $375M Covid-19 Antibody Supply Deal With US Government
US buys Lilly COVID antibody, as effectiveness questions remain
Bitcoin becoming less-risky as an investment, Novogratz says
Our Bizarre Economy 2.0 Is A Spending Based Illusion
It's Coming... A Huge Bond Buying Opportunity
AstraZeneca Says Its COVID-19 Vaccine Produces Robust Immune Response In Elderly Patients
AstraZeneca, Oxford allowed to resume Covid-19 vaccine trial in U.S. – WSJ
Blood of recovered Covid-19 patients shows little benefit as treatment
Roche wades deeper into Covid-19 fight, inking antiviral pact with $350M cash following Regeneron deal
Opko Health Rolls Out Multiplex COVID-19, Influenza A/B Test
Pfizer ‘ready to roll’ if BioNTech COVID-19 shot is approved
American Airlines Plans To Resume 737 MAX Flights In December
Fluidigm Soars 16% As Covid-19 Saliva Test Selected In US; Analyst Sees 78% Upside
Vaxart: An Alternative Opportunity in the COVID-19 Vaccine Landscape
Pfizer Plans To Apply For FDA's Emergency-Use Approval During Third Week Of November, CEO Says
To Vaccinate or not?
Moderna Kicks Off Rolling Submission Of Covid-19 Vaccine In Canada